Skip to main content
POOLBEG PHARMA PLC logo

POOLBEG PHARMA PLC — Investor Relations & Filings

Ticker · POLB ISIN · GB00BKPG7Z60 LEI · 213800UZ8WJLWYHBFL52 IL Manufacturing
Open in API
Filings indexed 160 across all filing types
Latest filing 2024-08-27 Investor Presentation
Country GB United Kingdom
Listing IL POLB

About POOLBEG PHARMA PLC

https://poolbegpharma.com/

Poolbeg Pharma PLC is a clinical-stage biopharmaceutical company that develops and commercializes medicines for diseases with high unmet medical needs. The company's lead asset, POLB 001, is a treatment designed to prevent Cytokine Release Syndrome (CRS), a severe side effect associated with cancer immunotherapies, with the aim of making these treatments safer and more accessible. Poolbeg is also advancing an oral GLP-1 program for obesity, offering a patient-friendly therapeutic option. The company utilizes an artificial intelligence (AI)-led discovery platform that analyzes data from human challenge trials to identify novel drug targets. This AI-driven approach aims to accelerate target identification, reduce costs, and lower development risks.

Recent filings

Filing Released Lang Actions
H.C. Wainwright Global Investment Conference
Investor Presentation Classification · 1% confidence The document is a formal announcement disseminated via RNS (Regulatory News Service), indicated by the 'RNS Number' header and the distribution details at the end. The content explicitly states that Poolbeg Pharma will be presenting at the 'H.C. Wainwright 26th Annual Global Investment Conference' and provides details about the presentation availability and one-on-one meetings. This type of announcement, detailing management's participation in an external investor conference, is best classified as an Investor Presentation (IP) announcement or, more broadly, a general regulatory announcement. Since the core purpose is to inform investors about management's upcoming engagement and presentation schedule at a specific investment conference, 'Investor Presentation' (IP) is the most specific fit, as it relates directly to investor outreach activities, even if the presentation itself is virtual. It is not a full report (10-K, IR), a transcript (CT), or a dividend notice (DIV). Given the context of presenting at an investment conference, IP is appropriate. The document length is substantial enough (7229 chars) that it is not merely a placeholder RPA.
2024-08-27 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains fields related to 'voting rights', 'shareholder(s)', and 'Date on which the threshold was crossed or reached'. This structure is characteristic of regulatory filings concerning changes in significant share ownership. The RNS Number (1241A) and the mention of the FCA (Financial Conduct Authority) confirm its regulatory nature. This directly corresponds to the definition of Major Shareholding Notification (MRQ).
2024-08-12 English
Voluntary Delisting from OTCQB Market
Delisting Announcement Classification · 1% confidence The document is a formal announcement disseminated via RNS (RNS Number : 9154X) from Poolbeg Pharma PLC. The core subject is the 'Voluntary Delisting from OTCQB Market'. This action—the removal of a company's stock from a trading exchange—directly corresponds to the definition of a Delisting Announcement. The document explicitly states the last day of trading and confirms the retention of the AIM listing. This fits the definition for 'Delisting Announcement' (DLST) perfectly, rather than a general regulatory filing (RNS) or a report announcement (RPA), as it is a specific corporate action announcement.
2024-07-26 English
Notification of Major Holdings
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled with 'RNS Number : 7535V' and contains the standard header/footer information associated with RNS (Regulatory News Service) announcements from the London Stock Exchange. The content itself is a 'TR-1: Standard form for notification of major holdings,' which details changes in share ownership thresholds by an individual (Michael Kelly). This type of filing, reporting changes in significant shareholdings, directly corresponds to the Major Shareholding Notification category (MRQ). Although RNS is a general category, MRQ is more specific and accurate for this content.
2024-07-10 English
Change of Registered Address
Regulatory Filings Classification · 1% confidence The document is very short (3896 characters) and announces a 'Change of Registered Address' for Poolbeg Pharma PLC. It is distributed via 'RNS Number' and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This format is characteristic of a general regulatory announcement that does not fit into the more specific categories like 10-K, ER, or DIV. Since it is a general regulatory notification distributed through the RNS system and doesn't fit other specific definitions (like DIRS, MANG, or DIV), the most appropriate fallback category is Regulatory Filings (RNS).
2024-07-02 English
Result of AGM
AGM Information Classification · 1% confidence The document explicitly states its purpose in the title: "Results of Annual General Meeting". It confirms that "all resolutions put to shareholders at the Company's Annual General Meeting held earlier today were duly passed." This directly corresponds to the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, or in this case, the results thereof. Although it is a short announcement, the content is specific to the AGM results, making AGM-R a better fit than the general RPA or RNS fallback.
2024-06-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.